Diabetes Metabolic Syndrome and Obesity-Targets and Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2023-05-09 ms3000000909608469 来自山西省

偏重的研究方向：糖尿病并发症
经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？

41 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2021-11-22 ms6000001781488545

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：糖尿病
经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2023-06-28 ay 来自北京

大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧

32 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2022-01-20 ms6000001368077955

投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊

68 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2023-04-22 ms1000001471890092 来自天津

提交之后没有收到邮件，状态是0E，正常吗各位大佬？

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2022-04-26 ms6000001781488545

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：糖尿病
经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2023-03-16 ms5000001014125810 来自新疆

审稿速度:1.0
偏重的研究方向：糖尿病
经验分享：返修以后被拒的可能性大不大？

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2023-03-13 ms5000001014125810 来自新疆

偏重的研究方向：临床
经验分享：2g状态被拒的多不多？好紧张

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2021-04-20 叶豪

审稿速度:1.0
偏重的研究方向：糖尿病并发症;氧化应激
经验分享：请问有没有人一审修回后被拒的呢？

89 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131068, encodeId=773d213106866, content=偏重的研究方向：糖尿病并发症 经验分享：已经2D两个月了，第一个审稿人回复了意见，第二个审稿人一直没接收，就一直等着，咋整啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Tue May 09 00:56:58 CST 2023, time=2023-05-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145301, encodeId=13ba21453010f, content=大家能查到这个期刊的最新影响因子嘛？我怎么差不到，不会被踢出SCI了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Wed Jun 28 23:26:43 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127747, encodeId=54b5212e74763, content=提交之后没有收到邮件，状态是0E，正常吗各位大佬？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d058390893, createdName=ms1000001471890092, createdTime=Sat Apr 22 22:22:59 CST 2023, time=2023-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120053, encodeId=fa912120053dd, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：返修以后被拒的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Thu Mar 16 22:09:23 CST 2023, time=2023-03-16, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2119233, encodeId=2fe92119233e1, content=偏重的研究方向：临床 经验分享：2g状态被拒的多不多？好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Mon Mar 13 18:19:57 CST 2023, time=2023-03-13, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]

2022-07-29 12381888m78暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问4C状态持续多久？

49 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务